MD Learning Channel - Neurosciences
EMERGENCY MEDICAL STROKE ASSESSMENT (EMSA)
Earlier identification of strokes will lead to earlier treatment and better outcomes. Are you properly equipped to identify a stroke? EMSA can help.
UTILIZING SEEG, THE ROSA ROBOT, & NEUROPACE IN EPILEPSY TREATMENT
Kristen Riley, MD, highlights some of the new technology being used at UAB Medicine for the surgical management of epilepsy patients, such as Stereoelectroencephalography (SEEG), the ROSA Robot, responsive neurostimulation with NeuroPace, and why this makes the UAB Epilepsy Center so unique.
AUTONOMIC FUNCTION TESTING
Learning Objective / Overview: Autonomic function testing is the category of electrodiagnostic and clinical neurophysiology testing that is employed in the evaluation of sympathetic and parasympathetic neural pathways. Examining the integrity of these pathways is necessary in objectively evaluating many neurologic and cardiac conditions like orthostatic hypotension, recurrent syncopal episodes, and postural orthostatic tachycardia syndrome (POTS). Neurologists often time need to evaluate the functions of the thinly myelinated and non-myelinated small nerve fibers. These population of fibers cannot be assessed by routine nerve conduction studies or electromyography. The presence of autonomic dysfunction is a key criterion for the diagnosis of a life threatening condition like multiple system atrophy that distinguishes it from other more benign parkinsonian syndromes.
Accreditation Statement:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education
Physician Marketing Manager, UAB Health System
The planners have no commercial affiliations to disclose.
Mohamed Kazamel, MD
Associate Professor of Medicine, UAB Department of Neurology
Dr. Kazamel has disclosed the following commercial interests:
- Akcel Therapeutics, BioStealth Therapeutics – Consulting Fee
Dr. Kazamel does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.
There is no commercial support for this activity.